Furthermore, the expression of SREBP2 and the total cholesterol levels were examined in CRC xenograft tissues, and the results indicated that the knockdown of SREBP2 was maintained in HT29 and SW620 xenograft tumors (Figure S4G-J). This evidence concerns the gene SREBF2 and colorectal carcinoma.